Evonik Industries has signed a definitive agreement for acquisition of PeroxyChem Netherlands from PeroxyChem Holdings. Subject to pending approval by the cartel authorities responsible, the business with its site in the Netherlands, the 47 employees, and the customer portfolio will be transferred to Evonik at the closing of the sale, which is expected to take place in the last quarter of 2015. No financial details are available.
The business will increase Evonik’s hydrogen peroxide (H2O2) capacity in Europe, and complements the company’s existing production network of three sites in Antwerp (Belgium), Rheinfelden (Germany), and Weissenstein (Austria). With an annual global capacity totalling more than 900,000 tonnes produced in 12 production plants, Evonik’s Resource Efficiency Segment is a leading supplier. With its offer of a range of H2O2 grades and services and its excellent geographical situation, Evonik has close proximity to its customers.
In the areas of medicine, pharmaceuticals, cosmetics, and foods the product is used for sterilisation as well as treatment of aseptic packaging materials. Hydrogen peroxide is also used in eco-friendly treatment of waste gases and wastewater as well as for disinfection purposes.